.jpeg)
What does Trifluridine Tipiracil Tablets (Lonsurf) treat?
Trifluridine tipiracil tablets (Lonsurf) is approved as a single agent or in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (HCC) who have previously received fluoropyrimidine, oxaliplatin, and irinotecan-based chemotherapy (an anti-VE GF biologic therapy (or, if RAS wild-type, anti-EGFR therapy), is also indicated for the treatment of adult patients with metastatic gastric or gastroesophageal junction adenocarcinoma who have received at least two prior chemotherapy regimens, including fluoropyrimidine, platinum, taxane, or irinotecan, and, if appropriate, HER2/neu-targeted therapy.
[ 免责声明 ] 本页面内容来自公开渠道（如FDA官网、Drugs官网、原研药厂官网等），仅供持有医疗专业资质的人员用于医学药学研究参考，不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市，不适用于中国境内销售和使用。如需治疗，请咨询正规医疗机构。本站不提供药品销售或代购服务。
